Drug "Bidop": egosi maka ojiji, analogs na reviews

Ọbara mgbali elu bụghị nanị na-eweta ịrịba erughị ala na-enwe ndidi, ma na-egbu. Iji normalize ya ọnọdụ, ọtụtụ ndị na-amalite ndiife ịgba akwụkwọ. Otú ọ dị, ndị ọkachamara na-arịba ama na-abawanye ala ọbara mgbali n'ụlọ dị nnọọ mfe karịa ala elu. Ya mere, ha nwere ike ikwu na iji ọgwụ ọjọọ eme, kpọmkwem haziri maka nzube a.

Otu n'ime ndị kasị ewu ewu na irè ịgba akwụkwọ maka ọbara mgbali bụ ọgwụ dị ka "Bidop". Egosi maka ojiji, analogs na n'ji reviews nke a nkwadebe ga-atụle mgbe e mesịrị. Ị ga-amụtakwa banyere otú kwesịrị ekwesị iji nke a ọgwụ ma ọ bụrụ na o nwere ọ bụla mmetụta na contraindications.

Description, ntọhapụ ụdị, nkwakọ ngwaahịa na mejupụtara nke ọgwụ ọjọọ

Drug "Bidop", analogues nke na-ere niile pharmacies, ọ na-abịa n'ụdị ìhè aja aja mbadamba na-acha odo odo isi na a film cover. Ha na-gburugburu, biconvex udi na "B1" marking na notch na nọmba "5" ( "10") n'okpuru.

The n'ọrụ mgwa nke ngwá ọrụ a rụrụ na bisoprolol hemifumarate. Dị ka ndị inyeaka mmiri, mgbe ahụ, na-eji ha dị ka lactose monohydrate, magnesium stearate, microcrystalline cellulose, crospovidone odo pigmenti ọkwa PB 22812 (13% odo ígwè oxide na 87% lactose monohydrate).

Ịzụta mkpụrụ ọgwụ "Bidop", ojiji nke bụ obligatory maka ndị mmadụ na ọbara mgbali elu, ọ bụ omume na blisters na Ukwu nke katọn karị.

Pharmacodynamic kwa ọgwụ

Gịnị bụ ọgwụ "Bidop"? Egosi maka ojiji nke ngwá ọrụ ruru ya pharmacological edinam. A ọgwụ bụ a nhọrọ β1-adrenergic blocker. Ọ dịghị ihe sympathomimetic mmetụta, na ọ dịghị ihe akpụkpọ ahụ kwụsie ike.

Weere na nkà mmụta ọgwụ ike nke na ẹsụhọde ọrụ nke renin, iji belata myocardial oxygen ina na belata ya contractility.

"Bidop" - a ọgwụ nke nwere antianginal, antiarrhythmic na antihypertensive Njirimara. N'igbochi myocardial β1-adrenergic anabata (na obere doses), ọ na-ebelata intracellular iga nke calcium ion ebelata njikọ nke mara ụlọikwuu si ATP (kpaliri site catecholamines) nwere a na-adịghị mma chronotropic, BATM, dromo- na inotropic edinam, na-slows conduction na excitability.

Mgbe uku na ọgwụgwọ dose nkwadebe na-egosi β2-adrenoceptor igbochi mmetụta.

Ná mmalite nke ọgwụ (mmalite ụbọchị), elu-eguzogide ndị vaskụla mgbidi na-enwekwukwa. Mgbe ụbọchị 3, ọ na-aghọ nso mbụ, ma budata belata mgbe ogologo oge ọgwụgwọ.

Njirimara nke ọgwụ

Gịnị bụ Njirimara pụta ụwa na agwọ ọrịa "Bidop"? The pharmacological edinam nke ọgwụ ruru ya mejupụtara.

The hypotensive mmetụta nke ọgwụ jikọtara a ọnụ ke nkeji olu nke ọbara, ọmịiko mmetuta nke elu vaskụla mgbidi ụdị, nakwa dị ka ike gwụ nke ọrụ nke renin-angiotensin usoro, mmetụta na ụjọ usoro na mweghachi nke nzaghachi nke na-abịa omume a ọnụ ke nsogbu.

Ọ bụrụ na ọbara mgbali na-amalite na ọgwụgwọ mmetụta nke ọgwụ maka ụbọchị ise. Ya obi ike edinam abịa ọnwa abụọ gasịrị.

The antianginal mmetụta mere site a ọgwụ? Product nkọwa "Bidop" na-akọ na ihe dị otú ahụ edinam na-akpata a gụnyere ya ná myocardial anụ ahụ oxygen. Nke a na-eme site na ọnụ ke obi ọnụego, ọnụ contractility, diastolic ogologo oge ma rụọ ọrụ ọbara ọkọnọ. N'ihi na-abawanye nke na diastolic mgbali na ventricles na stretchability nke muscle anụ ahụ oxygen ina nwere ike na-amụba.

Banyere antiarrhythmic Njirimara nke agwọ ọrịa, ọ bụ n'ihi na mkpochapu ihe na-eme ka arrhythmia (ebighị nke ọmịiko usoro, tachycardia, ọbara mgbali, mụbara Camp ịta). Ọzọkwa, ọgwụ na-egbochi ahụ AV-conduction na-ebelata ọnụego excitation nke pacemakers.

Olee ihe ndị ọzọ ndị na-pụta ụwa ọgwụ "Bidop"? Ntuziaka maka ojiji, nkọwa, reviews, ndị ọkachamara na-ekwu na mgbe na-ewere na nkezi ọgwụgwọ doses nke ngwá ọrụ, dị ka megide ndị na-abụghị nhọrọ β-blockers esichaghịzi akpọ utịp ke akụkụ na-β2-adrenergic anabata (pancreas, mọzụlụ, ọkpụkpụ-ụdị uru ahụ elu akwara , eriri akpa nwa na bronchial akpa), nakwa dị ka metabolism nke carbohydrates. Ọzọkwa, na-ewere na-ọgwụ retains sodium ion, na ahụ ike nke ya atherogenic edinam tụnyere na propranolol.

Kinetic parameters nke ọgwụ

Gịnị bụ kinetic Njirimara nke "Bidop" ọgwụ ọjọọ? Nleba adịghị enye azịza nke ajụjụ a. Ọ na-hụrụ naanị na ntụziaka. Dị ka nke a, mgbe ha natasịrị agwọ ọrịa ọ amịpụtara si ọbara site 80-90%. Iri nri na-enweghị mmetụta na nke a.

The kacha ịta nke nọ n'ọrụ mgwa na ọbara e dere mgbe 2-3 awa. A ọgwụ na-ejikọ na plasma-edozi na 30-32%. Ọ bụ ezigbo ihe ọjọọ gafee site na ọbara-ụbụrụ mgbochi na Plasenta.

About 50% nke ọgwụ na-gbanwee imeju. Nke a na-arụpụta ihe fọrọ-adịghị ejekwa ozi metabolites.

The ọkara ndụ nke agwọ ọrịa esịmde 12 awa. Odika 2% nke ọgwụ na-anyụpụ na bile na banyere 98% - by na akụrụ ya.

egosi

"Bidop" - bụghị naanị a hypotensive ọgwụ, ma mgbochi anginal na mgbochi arrhythmic n'ụlọnga. N'ihi ya, ọ na-kenyere na iji kpochapụ ọbara mgbali na iji gbochie exacerbation ji nke anụ rịaworo.

contraindications antihypertensive

Ugbu a, ị maara ihe mere gị mkpa ndị dị otú ahụ na nkà mmụta ọgwụ, dị ka "Bidop". Egosi na e ọkọnọ n'elu. Otú ọ dị, ọgwụ na ajụjụ na-machibidoro inye:

• ujo;
• daa;
• nnukwu odida nke obi;
• akpa ume edema;
• sinoatrial ngọngọ ;
• AV-mgbochi nke abụọ ma ọ bụ atọ ogo (na-enweghị electrostimulator);
• na-arịa ọrịa imi syndrome;
• bradycardia;
• decompensated-adịghị ala ala odida nke obi, na-achọ inotropic ọgwụ;
• Raynaud ọrịa ;
• hypotension;
• metabolic acidosis ;
• n'otu oge ochichi nke monoamine oxidase inhibitors (Mao ma e wezụga B-mode);
• cardiomegaly (na-enweghị obi ọdịda);
• bronchial ụkwara ume ọkụ na oké COPD;
• mgbanwe ndị na-elu mgbasa, karịsịa na mgbe e mesịrị nkebi;
• pheochromocytoma (na-enweghị na-ewere Alfa-blockers);
• uche ọgwụ umi ma ọ bụ ndị ọzọ beta-blockers;
• lactose ekweghị ibe nọrọ, malabsorption galactose / glucose na lactase erughi;
• underage.

Kpachara anya ọrụ

Egosi "Bidopa" ngwa na-depụtara na nchọ ntuziaka. Ọ na-kwuru na ihe ókè ịkpachara anya, a ọgwụ na-kenyere ọrịa na-arịa ọrịa shuga, gbasara akụrụ ma ọ bụ hepatic ọdịda, adịghị ala ala ụdị, myasthenia gravis, psoriasis, hyperthyroidism, AV-mgbochi nke mbụ ogo, Prinzmetal rịaworo, ịda mbà n'obi, allergies, a akụkọ ihe mere eme nke nnabata na a siri nri na merela agadi afọ.

The usoro na onunu ogwu nke agwọ ọrịa

N'ihi nzube dị aṅaa na otú iji ọgwụ ọgwụ "Bidop"? Egosi maka ojiji, ntụziaka nke ọgwụ na-ọkọnọ a n'isiokwu a.

Were onu mbadamba ọkacha mma na ụtụtụ na ihe efu afo. Ha agaghị ga-ata ata, ma ị ga imebi film mkpuchi.

The onunu ogwu nke gị n'ụlọnga a họọrọ n'otu n'otu. Iji mee nke a, jide n'aka na ịkpọ dọkịta gị.

Ya mere otú na-ewere ọgwụ ọjọọ, "Bidop"? Egosi maka ojiji - ma ọ bụ kama, ha ọnụnọ - na ọ bụ ihe dị oké mkpa ọnọdụ maka nzube nke ọgwụ.

Iji gbochie nnukwu agha nke rịaworo pectoris na ike n'okpuru ọnụnọ nke ọbara mgbali ọrịa na-nyere onye mbụ dose of ọgwụ hà 5 mg. Ọ na-e kwa ụbọchị, otu ugboro.

Ọ bụrụ na achọrọ, kpọmkwem ego ama ọkọri 10 mg. Na nke a multiplicity n'ikuku echekwara.

The kacha kwa onunu ogwu "Bidop" agwọ ọrịa bụ 20 mg.

Na ndị mmadụ na mkpọchị ọrụ nke akụrụ, nakwa dị ka oké imeju ọrịa kacha onunu ogwu bụ 10 mg kwa ụbọchị.

Dozie kpọmkwem ego nke ọgwụ maka ndị agadi bụ chọrọ.

ekwesighi mmetụta

Gịnị mmetụta nwere ike ime ka ọgwụ "Bidop"? Nleba egosi na o kwere omume omume nke ụfọdụ oghom mmetụta. Ha bụ:

• Akọrọ anya, bịara ikiri ọhụụ, ibelata salivation, conjunctivitis.
• Orthostatic hypotension, AV-ngọngọ, a siri ike ọnụ ke nsogbu, a ọnụ nke myocardial contractility, imi bradycardia, conduction disturbances infarction anụ ahụ, arrhythmia, ọdịdị ọdịda mgbaàmà nke gbasara obi ọrụ (adịghị ala ala), vasoconstriction, obi mgbu.
• Ike ọgwụgwụ, adịghị ike, ike ọgwụgwụ, ụra na-enwe nsogbu, mgbagwoju anya, myasthenia gravis, dizziness, na-arọ nrọ, paresthesia na nsọtụ, ịda mbà n'obi, nchegbu, isi ọwụwa, mara jijiji, ịmụ anya arọ nrọ, ọdụdọ.
• Gọzie gị mkpọchi, iku ume ọkụ ọkụ mgbe na-ewere ọgwụ na elu doses, ma ọ bụ na ndị mmadụ na a pụrụ ịrịa bronchospasm na laryngospasm.
• Ọgbụgbọ, ịba ọcha n'anya, nkụ ọnụ, nụrụ ụtọ rụrụ arụ na-, emesis, ọrịa nke imeju, afọ ntachi, hypertriglyceridemia, abdominal mgbu, afọ ọsịsa, hyperbilirubinemia, mụbara imeju enzymes kasịnụ.
• Exacerbation nke psoriasis, psoriasiform Jeremaya mere, anụ nācha ọbara-ọbara, ihe ọkụ ọkụ, mụbara sweating, alopecia.
• Hyperglycemia, hypothyroid ala, hypoglycemia (ndị mmadụ na-eji insulin).
• Thrombocytopenia, agranulocytosis, leukopenia.
• Arthralgia, belata potency, lumbodynia, esighịzi ike libido, torakalgiya, ndọrọ ego syndrome.
• Urticaria, pruritus, ihe ọkụ ọkụ.
• Bradycardia, intra-eriri akpa nwa ibu iberibe.

mgbaàmà nke ovadozu

Gịnị n'akụkụ ihe ịrịba ama hụrụ "Bidop" elu doses nke ọgwụ? Egosi maka ojiji nke ego na-abụghị nanị usoro na ọnọdụ maka ojiji. Ọ dị mkpa na-edebe ihe niile na onunu ogwu nke ọgwụ, nke e-atụ aro ndị ịga dibịa. Ọ bụrụ na anyị eleghara ndụmọdụ a, onye ọrịa nwere ike dị otú ahụ ihe ịrịba ama nke ovadozu ka bradycardia, ventricular arrythmia, cyanosis nke aka, arrhythmia, bronchospasm, AV-mgbochi, vertigo, elu nsogbu dobe, na-ada mbà, adịghị ala ala insufficiency nke gbasara obi ọrụ, cramps, ike iku ume na hypoglycemia.

Iji kpochapụ ndị dị otú ahụ na-ekwu, saa ndidi afo, chelators na-enye symptomatic ọgwụgwọ a rụrụ.

ọgwụ interactions

Ọ bụ dakọtara na ndị ọzọ pụtara "Bidop" (ọgwụ)? Site na ihe-eji nke a na nkà mmụta ọgwụ, anyị chọpụtara. Otú ọ dị, na Nchikota na ndị ọzọ ọgwụ ga-eji na oké ịkpachara anya.

"Bidopa" Mgbe intravenously "Phenytoin" nkwadebe, nakwa dị ka eji n'aka na-amụba cardiodepressive inhalation ná Nkụnwụ mmetụta.

Radiopaque ayodiin-nwere ọgwụ ọjọọ eme ihe maka igba ogwu n'akwara ochichi enwekwu ihe ize ndụ nke anaphylactic Jeremaya mere.

"Bidop" mgbe mgbe masks mgbaàmà nke na-emepe emepe hypoglycemia. Ọ na-enwekwu ịta nke xanthine na lidocaine ke iyịp.

Sympatholytics, diuretics, "Clonidine", "Nifedipine", "Hydralazine", na ndị ọzọ antihypertensive ọgwụ ọjọọ na Nchikota na "Bidopom" iduga a siri ike gụnyere ya ná nsogbu.

Tetracyclic na tricyclic antidepressants, na ethanol, hypnotics, sedatives na antipsychotics dịkwuo CNS ịda mbà n'obi.

kpọmkwem na-atụ aro

Gịnị onye ọrịa kwesịrị ịma tupu ewere mbadamba "Bidop"? Nyocha nke dọkịta na-ekwu na ná mmalite nke ọgwụgwọ, ọrịa mkpa ịkpachara anya ma na-elekọta mgbe ụzọ management.

Control nke ndị mmadụ na-eji ọgwụ ọjọọ n'okpuru echiche, na-agụnye ji atụ a nsogbu na usu àgwà, na-ekpebi ọbara sugar etoju na-eduzi ECG. Ndị agadi kwesịrị iso na-arụ ọrụ nke gbasara akụrụ usoro.

Tupu ọgwụgwọ dị mkpa iji mee nchoputa nke akụkụ okuku ume na ọrụ ọrịa na a akụkọ ihe mere eme nke akpa ume mere eme.

Na ọgwụgwọ nke ọrịa na pheochromocytoma nke ihe ize ndụ nke paradoxical ọbara mgbali.

Na-ese siga na beta-blockers obere irè.

Ọ bụrụ na ị chọrọ na-eduzi a zubere ịwa ahụ, ọgwụ a ga-kwụsịrị n'ihi na ụbọchị abụọ tupu general ná Nkụnwụ.

Na mmepe nke ịda mbà n'obi, ọgwụ ga-akwụsị.

Ọ na-machibidoro iwu na-sharply ịkwụsịtụ omume ruru ka ihe ize ndụ nke myocardial infarction ma ọ bụ gosi arrhythmias. The agwọ ọrịa na-kagbuo nwayọọ nwayọọ mbenata dose izu abụọ ma ọ bụ karịa.

Mbadamba "Bidop": ogbo na-eri

Ọ bụrụ na ọ dị mkpa, na-ewere ọgwụ nwere ike dochie anya dị otú ahụ dị ka "Bisokard", "Aritel Cor", "Tiresias", "Aritel", "Niperten", "Bidop Cor", "Kordinorm", "Biprol", "Coronal", "Biol "" CORBIS "," Bisogamma "" Concor "," bisoprolol "" Concor Cor "," Bisomor "," bisoprolol-OBL "," bisoprolol-Teva ".

The na-eri nke a antianginal, antiarrhythmic na antihypertensive ọgwụ ọjọọ bụ banyere 250-300 rubles (28 mbadamba).

Nyocha na ọgwụ

Ugbu a, ị maara, nke ọgwụ ike ga-ndinọ ka a "Bidop". Egosi maka ojiji, n'ji reviews nke agwọ ọrịa na ihe e kwuru n'isiokwu a.

Posts ọrịa na-egosi na ihe na-atụle a nnọọ irè n'aka. Mbadamba "Bidop" pụtara ngwa ngwa belata nsogbu na-ebelata ihe ịrịba ama niile nke ịrịa ọrịa obi.

Otú ọ dị, ọ ga-kwuru na nke a ọgwụ bụ nke ukwuu mgbe ndị na-akpata mmetụta. Ha nwere ike ime na akụkụ nke niile na akụkụ na usoro.

Anyị ga na-ekwukwa na 20% nke ndị na-rịaworo, ngwá ọrụ bụ adighi ike. Dọkịta na-akọwa nke a akpọ ọnụnọ nke akwara atherosclerosis, nakwa dị ka ihe na ụba diastolic olu nke ekpe ventricle.

Na enweghị mmetụta nke ọrịa ga-ahụ a dọkịta maka nhọpụta nke a ọgwụ.